Chevallard Daniel R. (CIK 1706176) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-30). Recent activity: Buy LENZ (7,500 shares), Buy LENZ (20 shares), Buy LENZ (2,178 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-30 | LENZ Therapeutics, Inc. (LENZ) | Chief Financial Officer | Buy | 7,500 | $64,275 |
| 2025-11-07 | LENZ Therapeutics, Inc. (LENZ) | Chief Financial Officer | Buy | 20 | $454 |
| 2025-11-07 | LENZ Therapeutics, Inc. (LENZ) | Chief Financial Officer | Buy | 2,178 | $49,571 |
Source: SEC Form 4 filings · as of 2026-03-30